News

US expands prescribing recommendations for aspirin

BMJ 1998; 317 doi: https://doi.org/10.1136/bmj.317.7167.1176 (Published 31 October 1998) Cite this as: BMJ 1998;317:1176
  1. Deborah Josefson
  1. San Francisco

    The US Food and Drug Administration (FDA) has substantially expanded its official prescribing recommendations and labelling requirements for aspirin to increase use in ischaemic heart disease and stroke.

    The effectiveness of aspirin in preventing heart attacks and limiting infarct size is widely known, but only about half of patients who have had a heart attack receive the drug, according to an advisory panel. Under the new ruling, …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe